We are rapidly moving toward a world in which broad sharing of participant-level clinical trial data is the norm. The European Medicines Agency has implemented a policy to expand public access to data concerning products it approves, the Food and Drug Administration is considering how to expand…
Clinical Trial Participants’ Views of the Risks and Benefits of Data Sharing
